Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Ribozyme RPI.4610

Known as: RPI-4610, RPI.4610, RPI4610 
A nuclease-stabilized synthetic ribozyme (ribonucleic acid enzyme) with potential anti-angiogenesis activity. Ribozyme RPI.4610 specifically… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
BACKGROUND Serum and plasma levels of vascular endothelial growth factor (VEGF) correlate with prognosis in patients with… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Review
2007
Review
2007
The prognosis for any patient with progressive or recurrent invasive transitional cell carcinoma remains poor. In this context… Expand
  • table 1
  • table 2
Is this relevant?
2004
2004
PurposeRPI.4610 (ANGIOZYME) is a chemically stabilized ribozyme targeting vascular endothelial growth factor receptor 1. The… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
2003
2003
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… Expand
Is this relevant?
1998
1998
Dr J. G. Duncan. Radiological diagnosis of metabolic bone disease. The metabolic bone diseases which were discussed were… Expand
Is this relevant?